Erratum: Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis (PLoS Pathogens (2013) 9:1 (e1003114) DOI: 10.1371/journal.ppat.1003114);Fine Tuning Inflammation at the Front Door: Macrophage Complement Receptor 3-mediates Phagocytosis and Immune Suppression for Francisella tularensis

PLoS Pathogens

Volumn 9, Issue 1, 2013, Pages

  Dai, Shipan ^a   Rajaram, Murugesan V S ^a   Curry, Heather M ^a   Leander, Rachel ^a   Schlesinger, Larry S ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C3 RECEPTOR; GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN KINASE B; PROTEIN KINASE LYN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FRANCISELLA TULARENSIS; GENE DELETION; GENE SILENCING; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INTRACELLULAR SIGNALING; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; WESTERN BLOTTING;

EID: 84875066771     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005504     Document Type: Erratum

References (95)

1. Evans ME, Gregory DW, Schaffner W, McGee ZA, (1985) Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 64: 251-269.
2. Thomas LD, Schaffner W, (2010) Tularemia pneumonia. Infect Dis Clin North Am 24: 43-55.
3. Kugeler KJ, Mead PS, Janusz AM, Staples JE, Kubota KA, et al. (2009) Molecular Epidemiology of Francisella tularensis in the United States. Clin Infect Dis 48: 863-870.
4. Staples JE, Kubota KA, Chalcraft LG, Mead PS, Petersen JM, (2006) Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. Emerg Infect Dis 12: 1113-1118.
5. Johansson A, Celli J, Conlan W, Elkins KL, Forsman M, et al. (2010) Objections to the transfer of Francisella novicida to the subspecies rank of Francisella tularensis. Int J Syst Evol Microbiol 60: 1717-1718.
6. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, et al. (2008) Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect Immun 76: 5843-5852.
7. Mariathasan S, Weiss DS, Dixit VM, Monack DM, (2005) Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med 202: 1043-1049.
8. Metzger DW, Bakshi CS, Kirimanjeswara G, (2007) Mucosal immunopathogenesis of Francisella tularensis. Ann N Y Acad Sci 1105: 266-283.
9. Collazo CM, Sher A, Meierovics AI, Elkins KL, (2006) Myeloid differentiation factor-88 (MyD88) is essential for control of primary in vivo Francisella tularensis LVS infection, but not for control of intra-macrophage bacterial replication. Microbes Infect 8: 779-790.
10. Golovliov I, Kuoppa K, Sjostedt A, Tarnvik A, Sandstrom G, (1996) Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. FEMS Immunol Med Microbiol 13: 239-244.
11. Golovliov I, Sandstrom G, Ericsson M, Sjostedt A, Tarnvik A, (1995) Cytokine expression in the liver during the early phase of murine tularemia. Infect Immun 63: 534-538.
12. Stenmark S, Sunnemark D, Bucht A, Sjostedt A, (1999) Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. Infect Immun 67: 1789-1797.
13. Bosio CM, Dow SW, (2005) Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J Immunol 175: 6792-6801.
14. Telepnev M, Golovliov I, Grundstrom T, Tarnvik A, Sjostedt A, (2003) Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell Microbiol 5: 41-51.
15. Telepnev M, Golovliov I, Sjostedt A, (2005) Francisella tularensis LVS initially activates but subsequently down-regulates intracellular signaling and cytokine secretion in mouse monocytic and human peripheral blood mononuclear cells. Microb Pathog 38: 239-247.
16. Bosio CM, Bielefeldt-Ohmann H, Belisle JT, (2007) Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol 178: 4538-4547.
17. Butchar JP, Cremer TJ, Clay CD, Gavrilin MA, Wewers MD, et al. (2008) Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS One 3: e2924.
18. Cremer TJ, Butchar JP, Tridandapani S, (2011) Francisella Subverts Innate Immune Signaling: Focus On PI3K/Akt. Front Microbiol 5: 13.
19. Balagopal A, MacFarlane AS, Mohapatra N, Soni S, Gunn JS, et al. (2006) Characterization of the receptor-ligand pathways important for entry and survival of Francisella tularensis in human macrophages. Infect Immun 74: 5114-5125.
20. Schulert GS, Allen LA, (2006) Differential infection of mononuclear phagocytes by Francisella tularensis: role of the macrophage mannose receptor. J Leukoc Biol 80: 563-571.
21. Clemens DL, Lee BY, Horwitz MA, (2005) Francisella tularensis enters macrophages via a novel process involving pseudopod loops. Infect Immun 73: 5892-5902.
22. Geier H, Celli J, (2011) Phagocytic receptors dictate phagosomal escape and intracellular proliferation of Francisella tularensis. Infect Immun 79: 2204-2214.
23. Barel M, Hovanessian AG, Meibom K, Briand JP, Dupuis M, et al. (2008) A novel receptor- ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. BMC Microbiol 8: 145.
24. Pierini LM, (2006) Uptake of serum-opsonized Francisella tularensis by macrophages can be mediated by class A scavenger receptors. Cell Microbiol 8: 1361-1370.
25. Clay CD, Soni S, Gunn JS, Schlesinger LS, (2008) Evasion of complement-mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J Immunol 181: 5568-5578.
26. Aderem AA, Wright SD, Silverstein SC, Cohn ZA, (1985) Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages. J Exp Med 161: 617-622.
27. Wright SD, Silverstein SC, (1983) Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J Exp Med 158: 2016-2023.
28. Stein M, Gordon S, (1991) Regulation of tumor necrosis factor (TNF) release by murine peritoneal macrophages: role of cell stimulation and specific phagocytic plasma membrane receptors. Eur J Immunol 21: 431-437.
29. Abram CL, Lowell CA, (2009) The ins and outs of leukocyte integrin signaling. Annu Rev Immunol 27: 339-362.
30. Hajishengallis G, Lambris JD, (2010) Crosstalk pathways between Toll-like receptors and the complement system. Trends Immunol 31: 154-163.
31. Hajishengallis G, Lambris JD, (2011) Microbial manipulation of receptor crosstalk in innate immunity. Nat Rev Immunol 11: 187-200.
32. Ivashkiv LB, (2009) Cross-regulation of signaling by ITAM-associated receptors. Nat Immunol 10: 340-347.
33. Harokopakis E, Hajishengallis G, (2005) Integrin activation by bacterial fimbriae through a pathway involving CD14, Toll-like receptor 2, and phosphatidylinositol-3-kinase. Eur J Immunol 35: 1201-1210.
34. Sendide K, Reiner NE, Lee JS, Bourgoin S, Talal A, et al. (2005) Cross-talk between CD14 and complement receptor 3 promotes phagocytosis of mycobacteria: regulation by phosphatidylinositol 3-kinase and cytohesin-1. J Immunol 174: 4210-4219.
35. Wang L, Gordon RA, Huynh L, Su X, Park Min KH, et al. (2010) Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 32: 518-530.
36. Han C, Jin J, Xu S, Liu H, Li N, et al. (2010) Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 11: 734-742.
37. Marth T, Kelsall BL, (1997) Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 185: 1987-1995.
38. Kim S, Chung EY, Ma X, (2005) Immunological consequences of macrophage-mediated clearance of apoptotic cells. Cell Cycle 4: 231-234.
39. Kim S, Elkon KB, Ma X, (2004) Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21: 643-653.
40. Oliva C, Turnbough CL Jr, Kearney JF, (2009) CD14-Mac-1 interactions in Bacillus anthracis spore internalization by macrophages. Proc Natl Acad Sci U S A 106: 13957-13962.
41. Cremer TJ, Ravneberg DH, Clay CD, Piper-Hunter MG, Marsh CB, et al. (2009) MiR-155 induction by F. novicida but not the virulent F. tularensis results in SHIP down-regulation and enhanced pro-inflammatory cytokine response. PLoS One 4: e8508.
42. Zarrella TM, Singh A, Bitsaktsis C, Rahman T, Sahay B, et al. (2011) Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One 6: e22335.
43. Gunn JS, Ernst RK, (2007) The structure and function of Francisella lipopolysaccharide. Ann N Y Acad Sci 1105: 202-218.
44. Cole LE, Shirey KA, Barry E, Santiago A, Rallabhandi P, et al. (2007) Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect Immun 75: 4127-4137.
45. Hong KJ, Wickstrum JR, Yeh HW, Parmely MJ, (2007) Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes. Infect Immun 75: 5338-5345.
46. Jones CL, Weiss DS, (2011) TLR2 Signaling Contributes to Rapid Inflammasome Activation during F. novicida Infection. PLoS One 6: e20609.
47. Katz J, Zhang P, Martin M, Vogel SN, Michalek SM, (2006) Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS. Infect Immun 74: 2809-2816.
48. Malik M, Bakshi CS, Sahay B, Shah A, Lotz SA, et al. (2006) Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect Immun 74: 3657-3662.
49. Abplanalp AL, Morris IR, Parida BK, Teale JM, Berton MT, (2009) TLR-dependent control of Francisella tularensis infection and host inflammatory responses. PLoS One 4: e7920.
50. Chen LM, Hobbie S, Galan JE, (1996) Requirement of CDC42 for Salmonella-induced cytoskeletal and nuclear responses. Science 274: 2115-2118.
51. Cole LE, Laird MH, Seekatz A, Santiago A, Jiang Z, et al. (2010) Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling. J Leukoc Biol 87: 275-281.
52. Huang MT, Mortensen BL, Taxman DJ, Craven RR, Taft-Benz S, et al. (2010) Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis. J Immunol 185: 5476-5485.
53. Rajaram MV, Brooks MN, Morris JD, Torrelles JB, Azad AK, et al. (2010) Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses. J Immunol 185: 929-942.
54. Kalli AC, Campbell ID, Sansom MS, (2011) Multiscale simulations suggest a mechanism for integrin inside-out activation. Proc Natl Acad Sci U S A 108: 11890-11895.
55. Ingalls RR, Arnaout MA, Golenbock DT, (1997) Outside-in signaling by lipopolysaccharide through a tailless integrin. J Immunol 159: 433-438.
56. Nagpal K, Plantinga TS, Wong J, Monks BG, Gay NJ, et al. (2009) A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling. J Biol Chem 284: 25742-25748.
57. Abram CL, Lowell CA, (2008) The diverse functions of Src family kinases in macrophages. Front Biosci 13: 4426-4450.
58. Kannan S, Audet A, Knittel J, Mullegama S, Gao GF, et al. (2006) Src kinase Lyn is crucial for Pseudomonas aeruginosa internalization into lung cells. Eur J Immunol 36: 1739-1752.
59. Keck S, Freudenberg M, Huber M, (2010) Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1. J Immunol 184: 5809-5818.
60. Ptasznik A, Nakata Y, Kalota A, Emerson SG, Gewirtz AM, (2004) Short interfering RNA (siRNA) targeting the Lyn kinase induces apoptosis in primary, and drug-resistant, BCR-ABL1(+) leukemia cells. Nat Med 10: 1187-1189.
61. Parsa KV, Ganesan LP, Rajaram MV, Gavrilin MA, Balagopal A, et al. (2006) Macrophage pro-inflammatory response to Francisella novicida infection is regulated by SHIP. PLoS Pathog 2: e71.
62. Medina EA, Morris IR, Berton MT, (2010) Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J Immunol 185: 7562-7572.
63. Pigazzi A, Heydrick S, Folli F, Benoit S, Michelson A, et al. (1999) Nitric oxide inhibits thrombin receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets. J Biol Chem 274: 14368-14375.
64. Kannan S, Audet A, Huang H, Chen LJ, Wu M, (2008) Cholesterol-rich membrane rafts and Lyn are involved in phagocytosis during Pseudomonas aeruginosa infection. J Immunol 180: 2396-2408.
65. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, et al. (2000) Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 1: 533-540.
66. Liu Y, Shepherd EG, Nelin LD, (2007) MAPK phosphatases-regulating the immune response. Nat Rev Immunol 7: 202-212.
67. Elkins KL, Leiby DA, Winegar RK, Nacy CA, Fortier AH, (1992) Rapid generation of specific protective immunity to Francisella tularensis. Infect Immun 60: 4571-4577.
68. Chen W, Kuolee R, Austin JW, Shen H, Che Y, et al. (2005) Low dose aerosol infection of mice with virulent type A Francisella tularensis induces severe thymus atrophy and CD4+CD8+ thymocyte depletion. Microb Pathog 39: 189-196.
69. Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM, (2008) Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Immun 76: 3001-3010.
70. Chase JC, Celli J, Bosio CM, (2009) Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect Immun 77: 180-195.
71. Ben Nasr A, Klimpel GR, (2008) Subversion of complement activation at the bacterial surface promotes serum resistance and opsonophagocytosis of Francisella tularensis. J Leukoc Biol 84: 77-85.
72. Leander R, Dai S, Schlesinger LS, Friedman A, (2012) A Mathematical Model of CR3/TLR2 Crosstalk in the Context of Francisella tularensis Infection. PLoS Comput Biol 8: e1002757.
73. Martin M, Schifferle RE, Cuesta N, Vogel SN, Katz J, et al. (2003) Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol 171: 717-725.
74. Guha M, Mackman N, (2002) The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem 277: 32124-32132.
75. Fukao T, Koyasu S, (2003) PI3K and negative regulation of TLR signaling. Trends Immunol 24: 358-363.
76. He JQ, Wiesmann C, van Lookeren Campagne M, (2008) A role of macrophage complement receptor CRIg in immune clearance and inflammation. Mol Immunol 45: 4041-4047.
77. Yamada M, Oritani K, Kaisho T, Ishikawa J, Yoshida H, et al. (2004) Complement C1q regulates LPS-induced cytokine production in bone marrow-derived dendritic cells. Eur J Immunol 34: 221-230.
78. Fraser DA, Arora M, Bohlson SS, Lozano E, Tenner AJ, (2007) Generation of inhibitory NFkappaB complexes and phosphorylated cAMP response element-binding protein correlates with the anti-inflammatory activity of complement protein C1q in human monocytes. J Biol Chem 282: 7360-7367.
79. Fraser DA, Bohlson SS, Jasinskiene N, Rawal N, Palmarini G, et al. (2006) C1q and MBL, components of the innate immune system, influence monocyte cytokine expression. J Leukoc Biol 80: 107-116.
80. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, et al. (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194: 781-795.
81. Wang M, Krauss JL, Domon H, Hosur KB, Liang S, et al. (2010) Microbial hijacking of complement-toll-like receptor crosstalk. Sci Signal 3: ra11.
82. Hajishengallis G, Shakhatreh MA, Wang M, Liang S, (2007) Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J Immunol 179: 2359-2367.
83. Hajishengallis G, Wang M, Liang S, Shakhatreh MA, James D, et al. (2008) Subversion of innate immunity by periodontopathic bacteria via exploitation of complement receptor-3. Adv Exp Med Biol 632: 203-219.
84. Brandhorst TT, Wuthrich M, Finkel-Jimenez B, Warner T, Klein BS, (2004) Exploiting type 3 complement receptor for TNF-alpha suppression, immune evasion, and progressive pulmonary fungal infection. J Immunol 173: 7444-7453.
85. Ricklin D, Hajishengallis G, Yang K, Lambris JD, (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11: 785-797.
86. Behrens EM, Sriram U, Shivers DK, Gallucci M, Ma Z, et al. (2007) Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity. J Immunol 178: 6268-6279.
87. Luo X, Liu L, Tang N, Lu KQ, McCormick TS, et al. (2005) Inhibition of monocyte-derived dendritic cell differentiation and interleukin-12 production by complement iC3b via a mitogen-activated protein kinase signalling pathway. Exp Dermatol 14: 303-310.
88. Schlesinger LS, Bellinger-Kawahara CG, Payne NR, Horwitz MA, (1990) Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol 144: 2771-2780.
89. Wilson ME, Pearson RD, (1988) Roles of CR3 and mannose receptors in the attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect Immun 56: 363-369.
90. Mosser DM, Vlassara H, Edelson PJ, Cerami A, (1987) Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J Exp Med 165: 140-145.
91. Payne NR, Horwitz MA, (1987) Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J Exp Med 166: 1377-1389.
92. Irani VR, Maslow JN, (2005) Induction of murine macrophage TNF-alpha synthesis by Mycobacterium avium is modulated through complement-dependent interaction via complement receptors 3 and 4 in relation to M. avium glycopeptidolipid. FEMS Microbiol Lett 246: 221-228.
93. Schonlau F, Scharffetter-Kochanek K, Grabbe S, Pietz B, Sorg C, et al. (2000) In experimental leishmaniasis deficiency of CD18 results in parasite dissemination associated with altered macrophage functions and incomplete Th1 cell response. Eur J Immunol 30: 2729-2740.
94. Brooks MN, Rajaram MV, Azad AK, Amer AO, Valdivia-Arenas MA, et al. (2011) NOD2 controls the nature of the inflammatory response and subsequent fate of Mycobacterium tuberculosis and M. bovis BCG in human macrophages. Cell Microbiol 13: 402-418.
95. Sweet L, Singh PP, Azad AK, Rajaram MV, Schlesinger LS, et al. (2010) Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids. Infect Immun 78: 518-526.